Skip to main content
OpenTrials

Clinical trial condition

Carcinoid Tumor

Explore clinical trials studying Carcinoid Tumor. Study availability and eligibility vary by location and protocol.

68 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Carcinoid Tumor trial results

Completed

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

NCT01327612

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
Locations
  • Research Site Duarte, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Tampa, Florida, United States
View Trial Details
Completed

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

NCT00446082

Conditions
Acromegaly, Adenocarcinoma, Bone Diseases, +18 more
Locations
  • Cedars Sinai Medical Center SC - 4 Los Angeles, California, United States
  • Stanford University Medical Center Stanford Cancer Center (3) Stanford, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H.LeeMoffittCC&RI(1) Tampa, Florida, United States
  • University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States
View all 17 locations
View Trial Details
Completed

A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer

NCT00781911

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +19 more
Locations
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Aurora, Colorado, United States
  • ImClone Investigational Site Atlanta, Georgia, United States
View Trial Details
Completed

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe

NCT00688623

Conditions
Adenocarcinoma, Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoid Tumor, +13 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Lyon, France
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Paris, France
View all 40 locations
View Trial Details
Completed

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

NCT01262235

Conditions
ACC, Adenocarcinoma, Adrenal Cortex Diseases, +26 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details

Related conditions